Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2013
12/03/2013CA2599411C Enzyme inhibitors
12/03/2013CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/03/2013CA2472678C Otoprotectant compositions of glutathione peroxidase mimics for ameliorating hearing loss
11/2013
11/30/2013CA2779184A1 Protein kinase inhibitors
11/28/2013WO2013177481A1 Benzodiazepines and conjugates thereof
11/28/2013WO2013177053A1 Pyrimidino [1, 2 -c] quinazolinone derivatives as tyrosine kinases inhibitors
11/28/2013WO2013176521A1 Organic light-emitting device and manufacturing method thereof
11/28/2013WO2013176325A1 Novel method for preparing fused heterocyclic compound using gilman reagent
11/28/2013WO2013175746A1 Organic electroluminescent element
11/28/2013WO2013175417A1 Pyrrolopyrrolidinone compounds
11/28/2013WO2013175206A1 Novel compounds
11/28/2013WO2013175205A1 Novel Compounds
11/28/2013WO2013174822A1 Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptors
11/28/2013WO2013174780A1 Substituted dipyridylamines and uses thereof
11/28/2013WO2013174743A1 Substituted pyrrolopyrimidines
11/28/2013WO2013174035A1 Method for preparing anhydrous crystal form i of sitagliptin phosphate
11/28/2013WO2013150495A3 Preparation of ticagrelor
11/28/2013US20130317220 NOVEL PROCESSES FOR PREPARING TRIAZOLO[4, 5-d]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF
11/28/2013US20130317211 Pyrrolo[2,1-c][1,4]naphthodiazepine Linked Piperazine Compounds and a Process for the Preparation Thereof
11/28/2013US20130317044 Novel carboxylic acid derivatives, their preparation and use
11/28/2013US20130317033 Substituted triazolo-pyridazine derivatives
11/28/2013US20130317024 Pyrrolopyrrolidinone compounds
11/28/2013US20130317022 7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
11/28/2013US20130317021 Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral disease
11/28/2013US20130317011 DIARYL ETHER LINKED PYRROLO [2,1-c][1,4] BENZODIAZEPINE HYBRIDS AND PROCESS FOR THE PREPARATION THEREOF
11/28/2013US20130317007 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
11/28/2013US20130317004 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/28/2013US20130317002 Fused pyrimidines
11/28/2013US20130315895 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
11/27/2013EP2666777A1 Certain chemical entities having an imidazo<4,5-b>pyrazin-2(3H)-one core, compositions and methods
11/27/2013EP2666776A1 Pyrazolopyrimidinone compound and imidazo-triazone compound for treating erectile dysfunction
11/27/2013EP2666775A1 Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
11/27/2013EP2666774A1 Beta-lactamase Inhibitors
11/27/2013EP2665729A1 Piperazine derivatives as cav2.2 calcium channel blockers
11/27/2013EP2665728A2 Preparation method of intermediate of sitagliptin
11/27/2013EP2665727A1 Bicyclic carboxamide inhibitors of kinases
11/27/2013EP2665726A2 Compositions and methods for cardiovascular disease
11/27/2013EP2665709A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
11/27/2013CN103415522A Tetraazaperopyrene compounds and their use as n-type semiconductors
11/27/2013CN103415521A 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace)
11/27/2013CN103415519A 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
11/27/2013CN103415518A Imidazopyrazines for use as MPS-1 and TKK inhibitors in the treatment hyperproliferative disorders
11/27/2013CN103415515A Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
11/27/2013CN103415513A Benzodioxane inhibitors of leukotriene production
11/27/2013CN103408552A Method for preparing Alisertib
11/27/2013CN103408551A Method for preparing Alisertib
11/27/2013CN103408550A 2,5-diketopiperazine dipeptide derived from lysobacter enzymogenes as well as preparation method and application thereof
11/27/2013CN103408549A Preparation method of alcaftadine intermediate
11/27/2013CN103408520A 3-[(2-fluoro-6-methoxyl) phenyl]-5-tetrachlorophthalide, as well as preparation method thereof
11/27/2013CN103405431A Opioid and opioid-like compounds and uses thereof
11/27/2013CN102686592B Copolymer containing fluorenylporphyrin-anthracene, preparation method and use thereof
11/27/2013CN102329325B Pyrrolopyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitors
11/27/2013CN102311447B Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor
11/27/2013CN101511835B 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors
11/26/2013US8592587 Transannular rearrangement of activated lactams
11/26/2013US8592580 Substituted triazinone derivatives
11/26/2013US8592579 Pyrrolotriazine kinase inhibitors
11/26/2013US8592577 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
11/26/2013US8592576 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
11/26/2013US8592446 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
11/26/2013US8592433 Compounds and compositions as protein kinase inhibitors
11/26/2013US8592432 Compounds and compositions as protein kinase inhibitors
11/26/2013US8592431 Fused ring compound and use thereof
11/26/2013US8592425 Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitors
11/26/2013US8592423 Inhibitors of PDE10
11/26/2013US8592422 Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptors
11/26/2013US8592407 Pyrrolo[2,1-c][1,4] benzodiazepine derivatives with dithiocarbamate side chains and process for the preparation thereof
11/26/2013US8592404 Derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy
11/26/2013CA2759399C Inhibitors of the renal outer medullary potassium channel
11/26/2013CA2590961C [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
11/21/2013WO2013173720A1 Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
11/21/2013WO2013171643A1 An improved process for preparation of irbesartan
11/21/2013WO2013171640A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013170774A1 Acetylene derivative having antineoplastic activity
11/21/2013WO2013170770A1 Acetylene derivatives having antitumor activity
11/21/2013WO2013170671A1 Pteridine ketone derivative and applications thereof as egfr, blk, and flt3 inhibitor
11/21/2013WO2013149001A3 Novel fused naphthalene cyclohetero ring compounds, and methods and uses thereof
11/21/2013WO2013084210A9 Amorphous form of sitagliptin salts
11/21/2013WO2012016095A8 Process for the preparation of the compound osi - 906
11/21/2013US20130310405 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the pi3k/akt pathway
11/21/2013US20130310394 Kinase inhibitors
11/21/2013US20130310368 Modulators of 5-ht receptors and methods of use thereof
11/21/2013US20130310364 Compositions and methods for inhibition of the jak pathway
11/21/2013US20130310363 Imidazopyrizine syk inhibitors
11/21/2013US20130310362 Fused pyrimidines
11/21/2013US20130310342 Aminopyrimidine Kinase Inhibitors
11/21/2013US20130309200 Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors
11/21/2013US20130309168 Bacterial imaging agents and methods of using same
11/20/2013EP2664620A2 N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline form and processes
11/20/2013EP2664618A2 Chemokine receptor modulators
11/20/2013EP2663567A1 Compounds for organic electroluminescent devices
11/20/2013EP2663566A1 5-([1,2,3]triazole-4-yl)-7h-pyrrolo[2,3-d]pyrimidine derivatives
11/20/2013EP2663565A2 Heteroaryl compounds and methods of use thereof
11/20/2013EP2663561A1 Novel heterocyclic derivatives and their use in the treatment of neurological disorders
11/20/2013EP2663555A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013EP2663550A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013EP2488523B1 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
11/20/2013EP2468717B1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
11/20/2013EP2285808B1 Spiro-indole derivatives for the treatment of parasitic diseases
11/20/2013EP2276085B1 Organic electroluminescent device
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 573